Advanced search
Publication Cover
Postgraduate Medicine Volume 128, 2016 - Issue 1
Submit an article Journal homepage
400
Views
6
CrossRef citations to date
0
Altmetric
Clinical Focus: Pain Management - Original Research

Why oral opioids may not be effective in a subset of chronic pain patients

Forest TennantResearch Department, Veract Intractable Pain Clinic, West Covina, CA91790-3043, USACorrespondence[email protected]
Pages 18-22 | Received 01 Oct 2015, Accepted 02 Dec 2015, Published online: 27 Dec 2015

References

  • Tennant F. Malabsorption of opioid medications. Pract Pain Mgt. 2013;13(6):31–34.
  • Tennant F. Opioid regimens in chronic pain patients with multiple cytochrome p450 defects. J Opioid Mgt. 2015;11(3):237–242.
  • Paine MF, Hart HL, Ludington SS, et al. The human intestinal cytochrome P450 “PIE.”. Drug Metab Dispos. 2006;34(5):880–886.
  • Zhang QY, Dunbar D, Ostrowel A, et al. Characterization of human small intestinal cytochromes P-450. Drug Metab Dispos. 1999;27:804–812.
  • Yang J, Tucker GT, Rostami-Hodejan A. Cytochrome P-450 3A4 expression and activity in the human small intestine. Clin Pharmacol Ther. 2004;76:391.
  • Obuch RS, Zhang QY, Dunbar D, et al. Metabolic characterization of the major human small intestinal cytochrome P-450s. Drug Metab Dispos. 2001;29:347–352.
  • Paine MF, Khalighi M, Fisher JM, et al. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther. 1997;283:1552–1562.
  • Paine MF, Schmiedlin-Ren P, Watkins PB. Cytochrome P-450 expression in human small bowel: interindividual variation and inhibition by ketoconazole. Drug Metab Dispos. 1999;27:360–364.
  • McQuaid KR. Diseases of the small intestine: malabsorption. In: Papadakis MA, McPhee SS, Rabow MW, editor. Lange 2015 current medical diagnosis and treatment. 54th ed. New York: McGraw-Hill Education; 2015. p. 617–619.
  • Schiller LR. Malabsorption. In: Bope ET, Kellerman RD, editor. Conn’s current therapy 2015. Philadelphia: Elsevier-Saunders; 2015. p. 581–586.
  • DiMayno MJ, DiMagno EP. Chronic pancreatitis. Curr Opin Gastrointerol. 2013;29:531–536.
  • Lai Ping SA, Mayer L. Gastrointestinal manifestations of primary immunodeficiency disorders. Semin Gastrintest Dis. 1997;82(1):22–32.
  • Husebye E. Gastrointestinal motility disorders and bacterial overgrowth. J Intern Med. 1995;23747:419–427.
  • Virally-Monad M, Tielman D, Kevarkian JP, et al. Chronic diarrhea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth. Diabetes Metab. 1998;24(6):530–536.
  • Karras PJ, Pfeifer MA. Diabetic gastrointestinal autonomic neuropathy. Curr Ther Endocrinol Metab. 1997;6:462–465.
  • Washington K, Stenzel TT, Buckley RV, et al. Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol. 1996;20(10):1240–1252.
  • Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2012;107(10):1474–1482.
  • Kaminsky LS, Zhang QY. The small intestine as a xenobiotic-metabolizing organ. Drug Metab Dispos. 2003;31:1520–1525.
  • Srinath A, Walter C, Newara MC, et al. Pain management in patients with inflammatory bowel disorder: insights for the clinician. Therap Adv Gastroenterol. 2012;5(5):339–357.
  • Graham DB, Xavier RJ. From genetics of inflammatory bowel disease towards mechanistic insights. Trenos Immunol. 2013;34(8):371–378.
  • Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Anna Rev Med. 2011;62:381–396.
  • Argoff CI. Clinical implications of opioid pharmacogenetics. Clin J Pain. 2010;26(Suppl 10):516–520.
  • Webster LR. Pharmacogenetics in pain management: the clinical need. Clin Lab Med. 2008;38(4):581–598.
  • Tennant F. Cytochrome P450 testing in high dose opioid patients. Prac Pain Mgmt. 2012;7:43–58.
  • Wilkinson CW, Pogulayan KF, Petrie EC, et al. High prevalence of chronic pituitary and target-organ hormone abnormalities after blast-related mild traumatic brain injury. Fron Neurol. 2012;3:1–12.
  • Krahulik D, Zapletalova J, Frysak Z, et al. Dysfunction of hypothalamic-hypophysial axis after traumatic brain injury in adults. J Neurosurg. 2010;113(3):561–564.
  • Urban RJ, Harris P, Maset B. Anterior hypopituitarism following traumatic brain injury. Brain Inj. 2005;19(5):349–353.
  • Ives JC, Alderman M, Strad SE. Hypopituitarism after multiple concussions: a retrospective case study in an adolescent male. J Athl Brain. 2007;42(5):431–439.
  • Agha A, Phillips J, O’Kelly P, et al. The natural history of post-traumatic hypopituitarism: implosions for assessment and treatment. Am J Med. 2006;1818(12):1416.
  • Almaretti G, Ghigo E. Traumatic brain injury and hypopituitarism. Scientific World J. 2005;15(5):777–781.
  • Tennant F. Opioid serum concentration in patients with chronic pain. J Palliat Med. 2007;10:1253–1254.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.